European health insurance rarely covers experimental stem-cell therapies for primary immunodeficiency. Private out-of-pocket payment is standard, ranging €4,000–8,500 per infusion. Clinical-trial participation may offer free or subsidised access. Some immunodeficiency foundations or rare-disease societies provide financial assistance to trial-enrolled patients. United Kingdom NHS cover is restricted to approved research protocols; private UK immunology clinics charge £3,500–7,500 per infusion. Families should explore clinical-trial eligibility, approved alternatives (gene therapy, HSCT), and foundation support before pursuing private stem-cell treatment.
Primary immunodeficiency stem-cell treatment costs typically range €4,000–8,000 per infusion, reflecting the complexity of immunological assessment and monitoring. Fetal stem cells, when used, incur higher sourcing and manufacturing costs than placental MSCs, potentially exceeding €8,000 per cycle. Repeat infusions are common; multi-cycle protocols may total €15,000–25,000. Extensive immunological testing — T-cell subset enumeration, T-cell proliferation assays, antibody titers, vaccine responses — adds €1,500–3,000 to each cycle. Hospital-based immunology programmes typically charge €4,500–7,000; private boutique immune-therapy centres may exceed €8,000. European centres (Germany, Spain, Italy, Austria) generally offer more structured pricing than boutique clinics.
האם אני מועמד? → · Primary Immunodeficiency: full overview → · עלות חוסר חיסוניות ראשוני → · Cost →
בדוקה רפואית על ידי צוות העריכה של StemCellAtlas עם Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) של קליניקת השותף Stem Plus (סופיה), כנגד הנחיות ISSCR, FDA ו-EMA. Educational information, not medical advice; figures indicative.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם